| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS44026744 | HTLV-1 | ENSG00000273079.7 | protein_coding | GRIN2B | No | No | 2904 | Q13224 |
| TVIS44010098 | HTLV-1 | ENSG00000273079.7 | protein_coding | GRIN2B | No | No | 2904 | Q13224 |
| TVIS44020528 | HTLV-1 | ENSG00000273079.7 | protein_coding | GRIN2B | No | No | 2904 | Q13224 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | GRIN2B |
|---|---|
| DrugBank ID | DB01956 |
| Drug Name | Taurine |
| Target ID | BE0000417 |
| UniProt ID | Q13224 |
| Regulation Type | inhibitor |
| PubMed IDs | 25833525 |
| Citations | Chan CY, Singh I, Magnuson H, Zohaib M, Bakshi KP, Le Francois B, Anazco-Ayala A, Lee EJ, Tom A, YeeMon K, Ragnauth A, Friedman E, Banerjee SP: Taurine Targets the GluN2b-Containing NMDA Receptor Subtype. Adv Exp Med Biol. 2015;803:531-44. doi: 10.1007/978-3-319-15126-7_43. |
| Groups | Approved; Nutraceutical |
| Direct Classification | Organosulfonic acids |
| SMILES | NCCS(O)(=O)=O |
| Pathways | Congenital Bile Acid Synthesis Defect Type II; Familial Hypercholanemia (FHCA); Bile Acid Biosynthesis; Zellweger Syndrome; Congenital Bile Acid Synthesis Defect Type III; Taurine and Hypotaurine Metabolism; 27-Hydroxylase Deficiency; Cerebrotendinous Xanthomatosis (CTX) |
| PharmGKB | PA451590 |
| ChEMBL | CHEMBL239243 |
